Clinical Trial Details

A Prospective Observational Cohort Study of Patients with Castration-Resistant Prostate Cancer (TRUMPET)

The purpose of this study is to describe patterns of care in CRPC patients, as well as health-related quality of life (HRQoL) outcomes associated with CRPC and its management.

This study will also describe factors influencing treatment decisions including reason(s) for treatment choices and triggers for treatment changes for CRPC as well as describe clinical outcomes based on patient characteristics.

Astellas ONC-MA-1004

Principal Investigator(s)

Sponsor(s)

Astellas Pharma Global Development, Inc.

Contact

Clinical Trials Office at [email protected] or 203.358.8879.

Location

Our website uses cookies

This website uses cookies to give you the very best experience. Your continued use of this site is considered permission by you to use cookies in this manner. Please review our Privacy Policy and Terms of Use for more information about the data we collect and the types of cookies we use. Please note, if you link off our website to a 3rd party site of any kind, that website has its own terms and conditions.